Paper · 10691732
ATR disruption leads to chromosomal fragmentation and early embryonic lethality.
Brown EJ and 1 other. Genes Dev, 2000. Cited by 762 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Papers, record 10691732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691732
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle Proteins | Major topic |
| Chromosome Aberrations | Major topic |
| Fetal Death | Major topic |
| Gene Expression Regulation, Developmental | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Animals | |
| Apoptosis | |
| Ataxia Telangiectasia Mutated Proteins | |
| BRCA1 Protein | |
| BRCA2 Protein | |
| Blastocyst | |
| Caspases | |
| Cell Transformation, Neoplastic | |
| DNA Repair | |
| Gene Targeting | |
| Genotype | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Mitosis | |
| Neoplasm Proteins | |
| Neoplasms, Experimental | |
| Transcription Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,925,639 | A role for ATR in the DNA damage-induced phosphorylation of p53. | Genes Dev | 1999 | https://conductscience.org/library/papers/9925639 | PubMed |
| 2 | 10,524,633 | 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. | Nature | 1999 | https://conductscience.org/library/papers/10524633 | PubMed |
| 3 | 10,198,641 | Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. | Mol Cell | 1999 | https://conductscience.org/library/papers/10198641 | PubMed |
| 4 | 10,550,055 | Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. | Science | 1999 | https://conductscience.org/library/papers/10550055 | PubMed |
| 5 | 2,422,760 | Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. | Science | 1986 | https://conductscience.org/library/papers/2422760 | PubMed |
| 6 | 8,348,613 | Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. | Cell | 1993 | https://conductscience.org/library/papers/8348613 | PubMed |
| 7 | 8,008,069 | A mammalian protein targeted by G1-arresting rapamycin-receptor complex. | Nature | 1994 | https://conductscience.org/library/papers/8008069 | PubMed |
| 8 | 7,922,305 | Tumor spectrum analysis in p53-mutant mice. | Curr Biol | 1994 | https://conductscience.org/library/papers/7922305 | PubMed |
| 9 | 7,923,116 | The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. | Cancer Res | 1994 | https://conductscience.org/library/papers/7923116 | PubMed |
| 10 | 7,926,756 | Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. | Genes Dev | 1994 | https://conductscience.org/library/papers/7926756 | PubMed |
1 to 10 of 36
See all 36 referencesCited by482
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 762 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,778,539 | Synthetic lethality in cancer: mechanisms, therapeutic exploitation and clinical translation. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42778539 | PubMed |
| 42,493,622 | Structural mechanism of TOPBP1 activating the ATR-ATRIP replication checkpoint kinase. | Nat Struct Mol Biol | 2026 | https://conductscience.org/library/papers/42493622 | PubMed |
| 42,423,258 | ATZ-1 promotes DNA replication efficiency to maintain normal meiotic function. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/42423258 | PubMed |
| 42,401,703 | PARG inhibition reduces ssDNA levels and limits RPA loading upon replication fork collapse. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42401703 | PubMed |
| 41,986,659 | ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41986659 | PubMed |
| 41,973,002 | ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41973002 | PubMed |
| 41,946,360 | The DNA damage response pathway is required for multiciliated cell differentiation. | Curr Biol | 2026 | https://conductscience.org/library/papers/41946360 | PubMed |
| 41,899,393 | Roles of DNA Damage Response Pathway in the Regulation of the Nuclear Envelope. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899393 | PubMed |
| 41,865,289 | An updated view on lagging strand DNA replication: implications for the replication stress response. | Cell Cycle | 2026 | https://conductscience.org/library/papers/41865289 | PubMed |
| 41,643,682 | Precise control of transcription condensates across S phase balances linker histone expression with DNA replication, ensuring genome stability. | Mol Cell | 2026 | https://conductscience.org/library/papers/41643682 | PubMed |
1 to 10 of 482
See all 482 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ATR | 545 | PubTator's text mining | https://conductscience.org/library/genes/545 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10691732
GET https://conductscience.org/api/papers/v1/10691732/references?page=2